Morgan Stanley Stereotaxis, Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Morgan Stanley holds 202,800 shares of STXS stock, worth $462,383. This represents 0.0% of its overall portfolio holdings.

Number of Shares

202,800

Previous 177,968 13.95%

Holding current value

$462,383

Previous $405,000 12.1%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$1.76 - $2.64 $43,704 - $65,556	24,832 Added 13.95%	202,800 $356,000
Q4 2024 Feb 14, 2025	BUY	$1.84 - $2.47 $31,649 - $42,486	17,201 Added 10.7%	177,968 $405,000
Q3 2024 May 14, 2025	BUY	$1.76 - $2.35 $147,037 - $196,328	83,544 Added 108.19%	160,767 $327,000
Q3 2024 Nov 14, 2024	BUY	$1.76 - $2.35 $147,037 - $196,328	83,544 Added 108.19%	160,767 $327,000
Q2 2024 May 14, 2025	SELL	$1.73 - $3.2 $174,288 - $322,384	-100,745 Reduced 56.61%	77,223 $140,000
Q2 2024 Oct 17, 2024	SELL	$1.73 - $3.2 $25,316 - $46,828	-14,634 Reduced 15.93%	77,223 $140,000
Q2 2024 Aug 14, 2024	SELL	$1.73 - $3.2 $25,316 - $46,828	-14,634 Reduced 15.93%	77,223 $140,000
Q1 2024 Oct 17, 2024	BUY	$1.74 - $3.16 $25,463 - $46,243	14,634 Added 18.95%	91,857 $239,000
Q1 2024 Aug 16, 2024	BUY	$1.74 - $3.16 $58,629 - $106,476	33,695 Added 57.93%	91,857 $239,000
Q1 2024 May 15, 2024	BUY	$1.74 - $3.16 $58,629 - $106,476	33,695 Added 57.93%	91,857 $239,000
Q4 2023 Aug 16, 2024	SELL	$1.42 - $1.96 $27,066 - $37,359	-19,061 Reduced 24.68%	58,162 $101,000
Q4 2023 Feb 13, 2024	BUY	$1.42 - $1.96 $48,579 - $67,053	34,211 Added 142.84%	58,162 $101,000
Q3 2023 Nov 15, 2023	SELL	$1.42 - $1.84 $2,838 - $3,678	-1,999 Reduced 7.7%	23,951 $37,000
Q2 2023 Aug 14, 2023	SELL	$1.51 - $2.27 $72,005 - $108,247	-47,686 Reduced 64.76%	25,950 $39,000
Q1 2023 May 15, 2023	BUY	$1.85 - $2.71 $51,418 - $75,321	27,794 Added 60.63%	73,636 $150,000
Q4 2022 Feb 14, 2023	SELL	$1.55 - $2.38 $49,944 - $76,688	-32,222 Reduced 41.28%	45,842 $94,000
Q3 2022 Nov 14, 2022	SELL	$1.75 - $2.62 $197,309 - $295,399	-112,748 Reduced 59.09%	78,064 $141,000
Q2 2022 Oct 27, 2022	BUY	$1.75 - $3.71 $267,858 - $567,860	153,062 Added 405.46%	190,812 $350,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $3.71 $267,858 - $567,860	153,062 Added 405.46%	190,812 $350,000
Q1 2022 Oct 27, 2022	SELL	$3.11 - $6.63 $476,022 - $1.01 Million	-153,062 Reduced 80.22%	37,750 $142,000
Q1 2022 May 13, 2022	BUY	$3.11 - $6.63 $57,102 - $121,733	18,361 Added 94.7%	37,750 $142,000
Q4 2021 Feb 14, 2022	SELL	$5.14 - $6.84 $2.35 Million - $3.12 Million	-456,725 Reduced 95.93%	19,389 $121,000
Q3 2021 Nov 15, 2021	BUY	$5.34 - $9.87 $2.54 Million - $4.7 Million	476,114 New	476,114 $2.56 Million

Others Institutions Holding STXS

# of Institutions

Shares Held

40.9M

Call Options Held

70.8K

Put Options Held

41.9K

View Full List

About Stereotaxis, Inc.

Ticker STXS
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,790,096
Market Cap $171M
Description
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...

More about STXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account